1 | hiv | 16,767 |
2 | mother-to-child | 394 |
3 | hiv/sti | 110 |
4 | hiv/hcv | 87 |
5 | hiv/std | 83 |
6 | hiv-hcv | 46 |
7 | sti/hiv | 42 |
8 | std/hiv | 29 |
9 | latently | 26 |
10 | hcv/hiv | 18 |
11 | tb/hiv | 18 |
12 | hiv-hbv | 17 |
13 | hiv/tb | 14 |
14 | hiv1 | 13 |
15 | candidial | 11 |
16 | hiv-1/hsv-2 | 11 |
17 | hiv-tuberculosis | 11 |
18 | hiv/hbv | 11 |
19 | anti-ssa | 10 |
20 | hbv/hcv | 10 |
21 | ifv | 10 |
22 | maternal-to-child | 10 |
23 | tb-hiv | 10 |
24 | chlamydiaceae | 8 |
25 | dual-contour | 8 |
26 | antiretroviral-based | 7 |
27 | egfr-mutation | 7 |
28 | ehv4 | 6 |
29 | hiv-i | 6 |
30 | htlv-iii/lav | 6 |
31 | chcv | 5 |
32 | chlamydia/gonorrhea | 5 |
33 | flc9 | 5 |
34 | hcv-hiv | 5 |
35 | materno-foetal | 5 |
36 | muco-semen | 5 |
37 | triple-h | 5 |
38 | acrodermatitis | 4 |
39 | echinococcal | 4 |
40 | hsv-2/hiv | 4 |
41 | sillicosis | 4 |
42 | waddlia | 4 |
43 | aids/hiv | 3 |
44 | cervical-cancer | 3 |
45 | e1e3e4-deleted | 3 |
46 | easy-to-treat | 3 |
47 | facility-acquired | 3 |
48 | hiv-ptb | 3 |
49 | hiv/hsv-2 | 3 |
50 | hiv/stds | 3 |
51 | negative/unknown | 3 |
52 | protein-aggregation | 3 |
53 | swab-only | 3 |
54 | 50,699 | 2 |
55 | 7836 | 2 |
56 | acute/recent | 2 |
57 | ewing´s | 2 |
58 | hepatitis-c-virus | 2 |
59 | hiv/hcv/sti | 2 |
60 | information/ | 2 |
61 | lung/airway | 2 |
62 | micro-/macroangiopathy | 2 |
63 | multiple-type | 2 |
64 | non-cytopathic | 2 |
65 | non-mp | 2 |
66 | nonformulary | 2 |
67 | pav1 | 2 |
68 | preprophylaxis | 2 |
69 | single-contour | 2 |
70 | superiority/non-inferiority | 2 |
71 | within-jail | 2 |
72 | 'ongoing | 1 |
73 | -resolved | 1 |
74 | 2-limb | 1 |
75 | 22826 | 1 |
76 | 2=intermittently | 1 |
77 | =cardiovascular | 1 |
78 | abdominal-biliary | 1 |
79 | acg-negative | 1 |
80 | alloherpesvirus | 1 |
81 | allophone | 1 |
82 | anti-coronaviral | 1 |
83 | antibacterial-susceptibility | 1 |
84 | antibody-resistant | 1 |
85 | anti‑hcv | 1 |
86 | assay-estimated | 1 |
87 | bacterial/virus | 1 |
88 | cardiac-marker | 1 |
89 | chorioamnionitis-associated | 1 |
90 | cocaine-relapse | 1 |
91 | control-surgically | 1 |
92 | daa-resistant | 1 |
93 | daughter/s | 1 |
94 | discharges/subtle | 1 |
95 | dominant-element | 1 |
96 | dq2/8 | 1 |
97 | dual-tropic/mixed | 1 |
98 | e6/e7mrna | 1 |
99 | energy-filtered | 1 |
100 | entry/baseline | 1 |
101 | fungally | 1 |
102 | gb/s | 1 |
103 | gonorrhea/chlamydial | 1 |
104 | gud/hiv-1 | 1 |
105 | h3.3-mutation | 1 |
106 | hcv-antibody | 1 |
107 | helminth-hiv-1 | 1 |
108 | high-hpv | 1 |
109 | hiv-leishmania | 1 |
110 | hookworn | 1 |
111 | host-to-host | 1 |
112 | hpv16-18 | 1 |
113 | hpv16/18/31 | 1 |
114 | hsv-2/hiv-1 | 1 |
115 | human-to-poultry | 1 |
116 | increasers | 1 |
117 | indirect-contact | 1 |
118 | insect-transmitted | 1 |
119 | leadership-supported | 1 |
120 | liquid-heat | 1 |
121 | low-surgical | 1 |
122 | malaria/ibi | 1 |
123 | maternal-neonate | 1 |
124 | mother-to-baby | 1 |
125 | mother-tochild | 1 |
126 | nanoparticle-labeled | 1 |
127 | nanorice | 1 |
128 | neurosurgery-were | 1 |
129 | nitrite-le | 1 |
130 | nitrite-rich | 1 |
131 | nixed | 1 |
132 | nocicpetive | 1 |
133 | non-hbeag | 1 |
134 | non-week-8 | 1 |
135 | noneffector | 1 |
136 | nonsecondary | 1 |
137 | nst/cst | 1 |
138 | on-request | 1 |
139 | ozzardi | 1 |
140 | pharma-cogenetic | 1 |
141 | pooled-probe | 1 |
142 | post-uds | 1 |
143 | postpractice | 1 |
144 | poxviral | 1 |
145 | predictive-biomarker | 1 |
146 | primary-stroke | 1 |
147 | provider-origin | 1 |
148 | replication-based | 1 |
149 | resident/attending | 1 |
150 | resting-perfusion | 1 |
151 | risk-reduction-oriented | 1 |
152 | russia-mitigating | 1 |
153 | saponin-lysed | 1 |
154 | stimulated-echo | 1 |
155 | suspected/proven | 1 |
156 | swap-dm2-assisted | 1 |
157 | thermal-injury | 1 |
158 | trans-oceanic | 1 |
159 | trans-shell | 1 |
160 | transovarial | 1 |
161 | trichomomas | 1 |
162 | trichomonal+bacterial+candidal | 1 |
163 | trichosomal | 1 |
164 | upper-genital-tract | 1 |
165 | wavepacket | 1 |
166 | well-addressed | 1 |
167 | winter-seasonal | 1 |
168 | within-household | 1 |
169 | z-contrast | 1 |
1 | 'ongoing | 1 |
2 | -resolved | 1 |
3 | 2-limb | 1 |
4 | 22826 | 1 |
5 | 2=intermittently | 1 |
6 | 50,699 | 2 |
7 | 7836 | 2 |
8 | =cardiovascular | 1 |
9 | abdominal-biliary | 1 |
10 | acg-negative | 1 |
11 | acrodermatitis | 4 |
12 | acute/recent | 2 |
13 | aids/hiv | 3 |
14 | alloherpesvirus | 1 |
15 | allophone | 1 |
16 | anti-coronaviral | 1 |
17 | anti-ssa | 10 |
18 | antibacterial-susceptibility | 1 |
19 | antibody-resistant | 1 |
20 | antiretroviral-based | 7 |
21 | anti‑hcv | 1 |
22 | assay-estimated | 1 |
23 | bacterial/virus | 1 |
24 | candidial | 11 |
25 | cardiac-marker | 1 |
26 | cervical-cancer | 3 |
27 | chcv | 5 |
28 | chlamydia/gonorrhea | 5 |
29 | chlamydiaceae | 8 |
30 | chorioamnionitis-associated | 1 |
31 | cocaine-relapse | 1 |
32 | control-surgically | 1 |
33 | daa-resistant | 1 |
34 | daughter/s | 1 |
35 | discharges/subtle | 1 |
36 | dominant-element | 1 |
37 | dq2/8 | 1 |
38 | dual-contour | 8 |
39 | dual-tropic/mixed | 1 |
40 | e1e3e4-deleted | 3 |
41 | e6/e7mrna | 1 |
42 | easy-to-treat | 3 |
43 | echinococcal | 4 |
44 | egfr-mutation | 7 |
45 | ehv4 | 6 |
46 | energy-filtered | 1 |
47 | entry/baseline | 1 |
48 | ewing´s | 2 |
49 | facility-acquired | 3 |
50 | flc9 | 5 |
51 | fungally | 1 |
52 | gb/s | 1 |
53 | gonorrhea/chlamydial | 1 |
54 | gud/hiv-1 | 1 |
55 | h3.3-mutation | 1 |
56 | hbv/hcv | 10 |
57 | hcv-antibody | 1 |
58 | hcv-hiv | 5 |
59 | hcv/hiv | 18 |
60 | helminth-hiv-1 | 1 |
61 | hepatitis-c-virus | 2 |
62 | high-hpv | 1 |
63 | hiv | 16,767 |
64 | hiv-1/hsv-2 | 11 |
65 | hiv-hbv | 17 |
66 | hiv-hcv | 46 |
67 | hiv-i | 6 |
68 | hiv-leishmania | 1 |
69 | hiv-ptb | 3 |
70 | hiv-tuberculosis | 11 |
71 | hiv/hbv | 11 |
72 | hiv/hcv | 87 |
73 | hiv/hcv/sti | 2 |
74 | hiv/hsv-2 | 3 |
75 | hiv/std | 83 |
76 | hiv/stds | 3 |
77 | hiv/sti | 110 |
78 | hiv/tb | 14 |
79 | hiv1 | 13 |
80 | hookworn | 1 |
81 | host-to-host | 1 |
82 | hpv16-18 | 1 |
83 | hpv16/18/31 | 1 |
84 | hsv-2/hiv | 4 |
85 | hsv-2/hiv-1 | 1 |
86 | htlv-iii/lav | 6 |
87 | human-to-poultry | 1 |
88 | ifv | 10 |
89 | increasers | 1 |
90 | indirect-contact | 1 |
91 | information/ | 2 |
92 | insect-transmitted | 1 |
93 | latently | 26 |
94 | leadership-supported | 1 |
95 | liquid-heat | 1 |
96 | low-surgical | 1 |
97 | lung/airway | 2 |
98 | malaria/ibi | 1 |
99 | maternal-neonate | 1 |
100 | maternal-to-child | 10 |
101 | materno-foetal | 5 |
102 | micro-/macroangiopathy | 2 |
103 | mother-to-baby | 1 |
104 | mother-to-child | 394 |
105 | mother-tochild | 1 |
106 | muco-semen | 5 |
107 | multiple-type | 2 |
108 | nanoparticle-labeled | 1 |
109 | nanorice | 1 |
110 | negative/unknown | 3 |
111 | neurosurgery-were | 1 |
112 | nitrite-le | 1 |
113 | nitrite-rich | 1 |
114 | nixed | 1 |
115 | nocicpetive | 1 |
116 | non-cytopathic | 2 |
117 | non-hbeag | 1 |
118 | non-mp | 2 |
119 | non-week-8 | 1 |
120 | noneffector | 1 |
121 | nonformulary | 2 |
122 | nonsecondary | 1 |
123 | nst/cst | 1 |
124 | on-request | 1 |
125 | ozzardi | 1 |
126 | pav1 | 2 |
127 | pharma-cogenetic | 1 |
128 | pooled-probe | 1 |
129 | post-uds | 1 |
130 | postpractice | 1 |
131 | poxviral | 1 |
132 | predictive-biomarker | 1 |
133 | preprophylaxis | 2 |
134 | primary-stroke | 1 |
135 | protein-aggregation | 3 |
136 | provider-origin | 1 |
137 | replication-based | 1 |
138 | resident/attending | 1 |
139 | resting-perfusion | 1 |
140 | risk-reduction-oriented | 1 |
141 | russia-mitigating | 1 |
142 | saponin-lysed | 1 |
143 | sillicosis | 4 |
144 | single-contour | 2 |
145 | std/hiv | 29 |
146 | sti/hiv | 42 |
147 | stimulated-echo | 1 |
148 | superiority/non-inferiority | 2 |
149 | suspected/proven | 1 |
150 | swab-only | 3 |
151 | swap-dm2-assisted | 1 |
152 | tb-hiv | 10 |
153 | tb/hiv | 18 |
154 | thermal-injury | 1 |
155 | trans-oceanic | 1 |
156 | trans-shell | 1 |
157 | transovarial | 1 |
158 | trichomomas | 1 |
159 | trichomonal+bacterial+candidal | 1 |
160 | trichosomal | 1 |
161 | triple-h | 5 |
162 | upper-genital-tract | 1 |
163 | waddlia | 4 |
164 | wavepacket | 1 |
165 | well-addressed | 1 |
166 | winter-seasonal | 1 |
167 | within-household | 1 |
168 | within-jail | 2 |
169 | z-contrast | 1 |
1 | information/ | 2 |
2 | helminth-hiv-1 | 1 |
3 | hsv-2/hiv-1 | 1 |
4 | gud/hiv-1 | 1 |
5 | hpv16/18/31 | 1 |
6 | pav1 | 2 |
7 | hiv1 | 13 |
8 | hiv-1/hsv-2 | 11 |
9 | hiv/hsv-2 | 3 |
10 | ehv4 | 6 |
11 | 22826 | 1 |
12 | 7836 | 2 |
13 | non-week-8 | 1 |
14 | dq2/8 | 1 |
15 | hpv16-18 | 1 |
16 | 50,699 | 2 |
17 | flc9 | 5 |
18 | chlamydia/gonorrhea | 5 |
19 | waddlia | 4 |
20 | hiv-leishmania | 1 |
21 | e6/e7mrna | 1 |
22 | anti-ssa | 10 |
23 | 2-limb | 1 |
24 | hiv/tb | 14 |
25 | hiv-ptb | 3 |
26 | non-cytopathic | 2 |
27 | trans-oceanic | 1 |
28 | pharma-cogenetic | 1 |
29 | nanoparticle-labeled | 1 |
30 | energy-filtered | 1 |
31 | facility-acquired | 3 |
32 | antiretroviral-based | 7 |
33 | replication-based | 1 |
34 | well-addressed | 1 |
35 | saponin-lysed | 1 |
36 | chorioamnionitis-associated | 1 |
37 | assay-estimated | 1 |
38 | e1e3e4-deleted | 3 |
39 | risk-reduction-oriented | 1 |
40 | leadership-supported | 1 |
41 | swap-dm2-assisted | 1 |
42 | insect-transmitted | 1 |
43 | -resolved | 1 |
44 | dual-tropic/mixed | 1 |
45 | nixed | 1 |
46 | maternal-to-child | 10 |
47 | mother-to-child | 394 |
48 | mother-tochild | 1 |
49 | within-household | 1 |
50 | hiv/std | 83 |
51 | chlamydiaceae | 8 |
52 | pooled-probe | 1 |
53 | nanorice | 1 |
54 | postpractice | 1 |
55 | primary-stroke | 1 |
56 | nitrite-le | 1 |
57 | discharges/subtle | 1 |
58 | entry/baseline | 1 |
59 | allophone | 1 |
60 | multiple-type | 2 |
61 | neurosurgery-were | 1 |
62 | cocaine-relapse | 1 |
63 | maternal-neonate | 1 |
64 | acg-negative | 1 |
65 | nocicpetive | 1 |
66 | non-hbeag | 1 |
67 | resident/attending | 1 |
68 | 'ongoing | 1 |
69 | russia-mitigating | 1 |
70 | triple-h | 5 |
71 | nitrite-rich | 1 |
72 | hiv-i | 6 |
73 | malaria/ibi | 1 |
74 | ozzardi | 1 |
75 | hiv/hcv/sti | 2 |
76 | hiv/sti | 110 |
77 | echinococcal | 4 |
78 | low-surgical | 1 |
79 | trichomonal+bacterial+candidal | 1 |
80 | candidial | 11 |
81 | gonorrhea/chlamydial | 1 |
82 | transovarial | 1 |
83 | trichosomal | 1 |
84 | winter-seasonal | 1 |
85 | anti-coronaviral | 1 |
86 | poxviral | 1 |
87 | materno-foetal | 5 |
88 | within-jail | 2 |
89 | trans-shell | 1 |
90 | muco-semen | 5 |
91 | suspected/proven | 1 |
92 | provider-origin | 1 |
93 | resting-perfusion | 1 |
94 | protein-aggregation | 3 |
95 | h3.3-mutation | 1 |
96 | egfr-mutation | 7 |
97 | hookworn | 1 |
98 | negative/unknown | 3 |
99 | stimulated-echo | 1 |
100 | non-mp | 2 |
101 | =cardiovascular | 1 |
102 | cervical-cancer | 3 |
103 | cardiac-marker | 1 |
104 | predictive-biomarker | 1 |
105 | noneffector | 1 |
106 | single-contour | 2 |
107 | dual-contour | 8 |
108 | gb/s | 1 |
109 | daughter/s | 1 |
110 | trichomomas | 1 |
111 | hiv/stds | 3 |
112 | post-uds | 1 |
113 | sillicosis | 4 |
114 | hiv-tuberculosis | 11 |
115 | acrodermatitis | 4 |
116 | preprophylaxis | 2 |
117 | increasers | 1 |
118 | hepatitis-c-virus | 2 |
119 | bacterial/virus | 1 |
120 | alloherpesvirus | 1 |
121 | ewing´s | 2 |
122 | liquid-heat | 1 |
123 | easy-to-treat | 3 |
124 | upper-genital-tract | 1 |
125 | indirect-contact | 1 |
126 | wavepacket | 1 |
127 | daa-resistant | 1 |
128 | antibody-resistant | 1 |
129 | acute/recent | 2 |
130 | dominant-element | 1 |
131 | z-contrast | 1 |
132 | nst/cst | 1 |
133 | on-request | 1 |
134 | host-to-host | 1 |
135 | htlv-iii/lav | 6 |
136 | hiv-hbv | 17 |
137 | hiv/hbv | 11 |
138 | hiv-hcv | 46 |
139 | hbv/hcv | 10 |
140 | hiv/hcv | 87 |
141 | chcv | 5 |
142 | anti‑hcv | 1 |
143 | ifv | 10 |
144 | hiv | 16,767 |
145 | tb-hiv | 10 |
146 | hcv-hiv | 5 |
147 | hsv-2/hiv | 4 |
148 | tb/hiv | 18 |
149 | std/hiv | 29 |
150 | sti/hiv | 42 |
151 | aids/hiv | 3 |
152 | hcv/hiv | 18 |
153 | high-hpv | 1 |
154 | lung/airway | 2 |
155 | mother-to-baby | 1 |
156 | hcv-antibody | 1 |
157 | micro-/macroangiopathy | 2 |
158 | control-surgically | 1 |
159 | fungally | 1 |
160 | swab-only | 3 |
161 | latently | 26 |
162 | 2=intermittently | 1 |
163 | nonsecondary | 1 |
164 | abdominal-biliary | 1 |
165 | nonformulary | 2 |
166 | human-to-poultry | 1 |
167 | thermal-injury | 1 |
168 | antibacterial-susceptibility | 1 |
169 | superiority/non-inferiority | 2 |